TGFBI/BIGH3 Monoclonal antibody 60007-1-Ig proteintech

$149.00
In stock
SKU
60007-1-Ig
Catalog No.SizePrice (USD)
60007-1-IG-20UL20 μL$149.00
60007-1-IG-150UL150 μL$449.00
60007-1-IG-10X150UL1.5 mL (10 x 150 μL vials)$3,592.00
Catalog Number60007-1-Ig
SynonymsTGFBI, TGFBI / BIGH3, 3E11D11, Beta ig h3, Beta ig-h3
HostMouse
Reactivityhuman and More (1)
Reactivityhuman, mouse
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF-P, IP, ELISA
Host / IsotypeMouse / IgG2a
Tested Applications — Positive WB detected inhuman kidney tissue
Tested Applications — Positive IP detected inHeLa cells
Tested Applications — Positive IHC detected inhuman colon tissue, human skin cancer tissue, human colon cancer tissue, human placenta tissue, human kidney tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Tested Applications — Positive IF-P detected inhuman colon cancer tissue
Recommended Dilutions — Western Blot (WB)WB : 1:500-1:2000
Recommended Dilutions — Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:500-1:2000
Recommended Dilutions — Immunofluorescence (IF)-PIF-P : 1:200-1:800
Positive WB detected inhuman kidney tissue
Positive IP detected inHeLa cells
Positive IHC detected inhuman colon tissue, human skin cancer tissue, human colon cancer tissue, human placenta tissue, human kidney tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF-P detected inhuman colon cancer tissue
Western Blot (WB)WB : 1:500-1:2000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:500-1:2000
Immunofluorescence (IF)-PIF-P : 1:200-1:800
Tested Reactivityhuman
Cited Reactivityhuman, mouse
ClassMonoclonal
TypeAntibody
ImmunogenCatNo: Ag0241 Product name: Recombinant human BIGH3 protein Source: e coli. -derived, PGEX-4T Tag: GST Domain: 199-406 aa of BC000097 Sequence: NIQIHHYPNGIVTVNCARLLKADHHATNGVVHLIDKVISTITNNIQQIIEIEDTFETLRAAVAASGLNTMLEGNGQYTLLAPTNEAFEKIPSETLNRILGDPEALRDLLNNHILKSAMCAEAIVAGLSVETLEGTTLEVGCSGDMLTINGKAIISNKDILATNGVIHYIDELLIPDSAKTLFELAAESDVSTAIDLFRQAGLGNHLSG Predict reactive species
Full Nametransforming growth factor, beta-induced, 68kDa
Calculated Molecular Weight683 aa, 75 kDa
Observed Molecular Weight68 kDa
GenBank Accession NumberBC000097
Gene SymbolTGFBI
Gene ID (NCBI)7045
ENSEMBL Gene IDENSG00000120708
RRIDAB_10896828
ConjugateUnconjugated
Purification MethodProtein A purification
UNIPROT IDQ15582
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IF protocol for TGFBI/BIGH3 antibody 60007-1-IgDownload protocol
IHC protocol for TGFBI/BIGH3 antibody 60007-1-IgDownload protocol
IP protocol for TGFBI/BIGH3 antibody 60007-1-IgDownload protocol
WB protocol for TGFBI/BIGH3 antibody 60007-1-IgDownload protocol
mouse,humanWB,IHC Cancer Res TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer. Authors - Laura S M Lecker View Article
humanWB,IHC Neoplasia BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation. Authors - Tianhong Pan KD Validated View Article
Citations9
DilutionsWB : 1:500-1:2000 IP : 0.5-4.0 ug for IP and 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate for WB IHC : 1:500-1:2000 IF-P : 1:200-1:800
IsotypeIgG2a
ClonalityMonoclonal
Clone Number3E11D11
ConjugationUnconjugated

TGFBI, also named as BIGH3, Kerato-epithelin and RGD-CAP, binds to type I, II, and IV collagens. TGFBI is an adhesion protein which may play an important role in cell-collagen interactions. In cartilage, it may be involved in endochondral bone formation. TGFBI is an extracellular matrix adaptor protein, it has been reported to be differentially expressed in transformed tissues. TGFBI is a predictive factor of the response to chemotherapy, and suggest the use of TGFBI-derived peptides as possible therapeutic adjuvants for the enhancement of responses to chemotherapy.(PMID:20509890) Defects in TGFBI are the cause of epithelial basement membrane corneal dystrophy (EBMD). Defects in TGFBI are the cause of corneal dystrophy Groenouw type 1 (CDGG1). Defects in TGFBI are the cause of corneal dystrophy lattice type 1 (CDL1). Defects in TGFBI are a cause of corneal dystrophy Thiel-Behnke type (CDTB). Defects in TGFBI are the cause of Reis-Buecklers corneal dystrophy (CDRB). Defects in TGFBI are the cause of lattice corneal dystrophy type 3A (CDL3A). Defects in TGFBI are the cause of Avellino corneal dystrophy (ACD). Protocols Product Specific Protocols IF protocol for TGFBI/BIGH3 antibody 60007-1-Ig Download protocol IHC protocol for TGFBI/BIGH3 antibody 60007-1-Ig Download protocol IP protocol for TGFBI/BIGH3 antibody 60007-1-Ig Download protocol WB protocol for TGFBI/BIGH3 antibody 60007-1-Ig Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer.
    Journal: Cancer Res | Authors: Laura S M Lecker | Species: mouse,human | Application: WB,IHC
  2. Deep spatial proteomics reveals region-specific features of severe COVID-19-related pulmonary injury
    Journal: Cell Rep | Authors: Yiheng Mao | Species: human | Application: IF
  3. Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells.
    Journal: Int J Cancer | Authors: Ween Miranda P MP | Species: human | Application: WB,IHC
  4. TGFbeta-induced protein mediates lymphatic endothelial cell adhesion to the extracellular matrix under low oxygen conditions.
    Journal: Cell Mol Life Sci | Authors: Irigoyen M M | Species: human | Application: WB
  5. Identification of Hub Genes Associated With Sensitivity of 5-Fluorouracil Based Chemotherapy for Colorectal Cancer by Integrated Bioinformatics Analysis.
    Journal: Front Oncol | Authors: Ya Wang | Species: human | Application: WB
  6. BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation.
    Journal: Neoplasia | Authors: Tianhong Pan KD Validated | Species: human | Application: WB,IHC
  7. Identification of Hub Genes Associated With Sensitivity of 5-Fluorouracil Based Chemotherapy for Colorectal Cancer by Integrated Bioinformatics Analysis.
    Journal: Front Oncol | Authors: Ya Wang | Species: human | Application: WB
  8. Absence of Vitamin K-Dependent γ-Carboxylation in Human Periostin Extracted from Fibrotic Lung or Secreted from a Cell Line Engineered to Optimize γ-Carboxylation.
    Journal: PLoS One | Authors: Douglas S Annis | Species: human | Application: WB
  9. Modified BIGH3 with an RGDRGD motif promotes human corneal epithelial cell adhesion and migration in vitro.
    Journal: Curr Eye Res | Authors: Ge Hongyan H | Species: human | Application: WB

Reviews

Write Your Own Review
You're reviewing:TGFBI/BIGH3 Monoclonal antibody 60007-1-Ig proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.